Terms: = Kidney tumors AND TAL1, TCL5, 6886, ENSG00000162367, SCL, P17542, tal-1 AND Treatment
4 results:
1. Risk factors for acute and chronic postoperative pain in patients with benign and malignant renal disease after nephrectomy.
Gerbershagen HJ; Dagtekin O; Rothe T; Heidenreich A; Gerbershagen K; Sabatowski R; Petzke F; Ozgür E
Eur J Pain; 2009 Sep; 13(8):853-60. PubMed ID: 19010073
[TBL] [Abstract] [Full Text] [Related]
2. Plasma activity of prolyl endopeptidase in relation to psychopathology during immunotherapy with IFN-alpha in patients with renal cell carcinoma.
Van Gool AR; Verkerk R; Fekkes D; Sleijfer S; Bannink M; Kruit WH; van der Holt B; Scharpé S; Eggermont AM; Stoter G; Hengeveld MW
J Interferon Cytokine Res; 2008 May; 28(5):283-6. PubMed ID: 18547158
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis.
Aguiar Bujanda D; Bohn Sarmiento U; Cabrera Suárez MA; Aguiar Morales J
Ann Oncol; 2007 Mar; 18(3):556-60. PubMed ID: 17082512
[TBL] [Abstract] [Full Text] [Related]
4. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
Sanada S; Ogura K; Kiriyama T; Yoshida O
Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
[TBL] [Abstract] [Full Text] [Related]
